Published in Clin Sci (Lond) on August 01, 2015
Endothelial functions of platelet/endothelial cell adhesion molecule-1 (CD31). Curr Opin Hematol (2016) 0.83
Circulating IGF-1 deficiency exacerbates hypertension-induced microvascular rarefaction in the mouse hippocampus and retrosplenial cortex: implications for cerebromicrovascular and brain aging. Age (Dordr) (2016) 0.78
Treatment of chronic ulcer in diabetic rats with self assembling nanofiber gel encapsulated-polydeoxyribonucleotide. Am J Transl Res (2016) 0.78
Unique aspects of the developing lung circulation: structural development and regulation of vasomotor tone. Pulm Circ (2016) 0.75
Role of Klotho in migration and proliferation of human dermal microvascular endothelial cells. Microvasc Res (2016) 0.75
Traditional Chinese Medicine ShenZhuGuanXin Granules Mitigate Cardiac Dysfunction and Promote Myocardium Angiogenesis in Myocardial Infarction Rats by Upregulating PECAM-1/CD31 and VEGF Expression. Evid Based Complement Alternat Med (2017) 0.75
Coronary angiogenic effect of long-term administration of Nigella sativa. BMC Complement Altern Med (2017) 0.75
The role of microvessel density, lymph node metastasis, and tumor size as prognostic factors of distant metastasis in colorectal cancer. Oncol Lett (2017) 0.75
Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature (2003) 20.48
Mechanisms of angiogenesis. Nature (1997) 18.04
Angiogenesis in life, disease and medicine. Nature (2005) 15.36
Angiogenesis in health and disease. Nat Med (2003) 14.02
Flow-mediated endothelial mechanotransduction. Physiol Rev (1995) 10.13
Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth. Nat Med (2001) 9.53
Mechanism of activation of the TGF-beta receptor. Nature (1994) 8.10
Regulation of cell motility by mitogen-activated protein kinase. J Cell Biol (1997) 7.14
A mechanosensory complex that mediates the endothelial cell response to fluid shear stress. Nature (2005) 6.86
Non-Smad pathways in TGF-beta signaling. Cell Res (2009) 5.54
Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1. Nat Med (2002) 5.50
Common mechanisms of nerve and blood vessel wiring. Nature (2005) 5.46
Balancing the activation state of the endothelium via two distinct TGF-beta type I receptors. EMBO J (2002) 5.44
Vasculogenesis. Annu Rev Cell Dev Biol (1995) 5.41
Endothelial cell-cell junctions: happy together. Nat Rev Mol Cell Biol (2004) 5.37
PECAM-1 (CD31) cloning and relation to adhesion molecules of the immunoglobulin gene superfamily. Science (1990) 5.28
PECAM-1 is required for transendothelial migration of leukocytes. J Exp Med (1993) 4.81
GS domain mutations that constitutively activate T beta R-I, the downstream signaling component in the TGF-beta receptor complex. EMBO J (1995) 4.63
Defective angiogenesis in mice lacking endoglin. Science (1999) 4.40
Signalling to and from tight junctions. Nat Rev Mol Cell Biol (2003) 4.37
The emerging concept of vascular remodeling. N Engl J Med (1994) 4.27
Integrins in angiogenesis and lymphangiogenesis. Nat Rev Cancer (2008) 4.27
Endothelial cell-to-cell junctions: molecular organization and role in vascular homeostasis. Physiol Rev (2004) 4.12
VEGF regulates haematopoietic stem cell survival by an internal autocrine loop mechanism. Nature (2002) 4.10
Placental growth factor reconstitutes hematopoiesis by recruiting VEGFR1(+) stem cells from bone-marrow microenvironment. Nat Med (2002) 4.00
Molecular and cellular properties of PECAM-1 (endoCAM/CD31): a novel vascular cell-cell adhesion molecule. J Cell Biol (1991) 3.91
Targeting of nitric oxide synthase to endothelial cell caveolae via palmitoylation: implications for nitric oxide signaling. Proc Natl Acad Sci U S A (1996) 3.83
Activin receptor-like kinase (ALK)1 is an antagonistic mediator of lateral TGFbeta/ALK5 signaling. Mol Cell (2003) 3.80
Acylation targets emdothelial nitric-oxide synthase to plasmalemmal caveolae. J Biol Chem (1996) 3.75
AMP-activated protein kinase phosphorylation of endothelial NO synthase. FEBS Lett (1999) 3.63
A human endothelial cell-restricted, externally disposed plasmalemmal protein enriched in intercellular junctions. J Exp Med (1989) 3.58
Endoglin is a component of the transforming growth factor-beta receptor system in human endothelial cells. J Biol Chem (1992) 3.57
Physiological actions and clinical applications of transforming growth factor-beta (TGF-beta). Growth Factors (1993) 3.43
Endoglin promotes endothelial cell proliferation and TGF-beta/ALK1 signal transduction. EMBO J (2004) 3.17
Transforming growth factor-beta: vasculogenesis, angiogenesis, and vessel wall integrity. Cytokine Growth Factor Rev (1997) 3.11
Breaking through the tight junction barrier. J Cell Biol (1993) 3.01
Endoglin is an accessory protein that interacts with the signaling receptor complex of multiple members of the transforming growth factor-beta superfamily. J Biol Chem (1999) 2.77
Role of plasmalemmal caveolae in signal transduction. Am J Physiol (1998) 2.77
Endoglin (CD105): a marker of tumor vasculature and potential target for therapy. Clin Cancer Res (2008) 2.75
The tyrosine phosphatase Shp2 (PTPN11) in cancer. Cancer Metastasis Rev (2008) 2.74
Platelet endothelial cell adhesion molecule-1 (PECAM-1/CD31): alternatively spliced, functionally distinct isoforms expressed during mammalian cardiovascular development. Development (1994) 2.71
EndoCAM: a novel endothelial cell-cell adhesion molecule. J Cell Biol (1990) 2.71
TGF-beta receptor function in the endothelium. Cardiovasc Res (2005) 2.68
Nitric oxide as a signaling molecule in the vascular system: an overview. J Cardiovasc Pharmacol (1999) 2.66
Embryonic death of Mek1-deficient mice reveals a role for this kinase in angiogenesis in the labyrinthine region of the placenta. Curr Biol (1999) 2.65
Genetic evidence for functional redundancy of Platelet/Endothelial cell adhesion molecule-1 (PECAM-1): CD31-deficient mice reveal PECAM-1-dependent and PECAM-1-independent functions. J Immunol (1999) 2.55
Altered vascular permeability and early onset of experimental autoimmune encephalomyelitis in PECAM-1-deficient mice. J Clin Invest (2002) 2.50
Endoglin, an ancillary TGFbeta receptor, is required for extraembryonic angiogenesis and plays a key role in heart development. Dev Biol (2000) 2.50
PECAM-1: a multi-functional molecule in inflammation and vascular biology. Arterioscler Thromb Vasc Biol (2007) 2.46
A novel endocytic pathway induced by clustering endothelial ICAM-1 or PECAM-1. J Cell Sci (2003) 2.34
Role of calcium and calmodulin in flow-induced nitric oxide production in endothelial cells. Am J Physiol (1994) 2.31
Signal transduction pathways mediated by PECAM-1: new roles for an old molecule in platelet and vascular cell biology. Arterioscler Thromb Vasc Biol (2003) 2.30
The Golgi association of endothelial nitric oxide synthase is necessary for the efficient synthesis of nitric oxide. J Biol Chem (1995) 2.20
Involvement of endothelial PECAM-1/CD31 in angiogenesis. Am J Pathol (1997) 2.17
Monoclonal antibody to murine PECAM-1 (CD31) blocks acute inflammation in vivo. J Exp Med (1994) 2.16
Evidence for a role of platelet endothelial cell adhesion molecule-1 in endothelial cell mechanosignal transduction: is it a mechanoresponsive molecule? J Cell Biol (2002) 2.03
Role of PECAM-1 in the shear-stress-induced activation of Akt and the endothelial nitric oxide synthase (eNOS) in endothelial cells. J Cell Sci (2005) 1.95
CD31/PECAM-1 is a ligand for alpha v beta 3 integrin involved in adhesion of leukocytes to endothelium. J Cell Biol (1995) 1.93
Shear stress affects the intracellular distribution of eNOS: direct demonstration by a novel in vivo technique. Blood (2005) 1.92
The structure and regulation of tight junctions. Curr Opin Cell Biol (1993) 1.89
The molecular functions of Shp2 in the Ras/Mitogen-activated protein kinase (ERK1/2) pathway. Cell Signal (2007) 1.82
Migration of monocytes across endothelium and passage through extracellular matrix involve separate molecular domains of PECAM-1. J Exp Med (1995) 1.81
Targeting cancer vasculature via endoglin/CD105: a novel antibody-based diagnostic and therapeutic strategy in solid tumours. Cardiovasc Res (2009) 1.78
Angiogenic and angiostatic factors in the molecular control of angiogenesis. Q J Nucl Med (2003) 1.71
Vascular mechanobiology: endothelial cell responses to fluid shear stress. Circ J (2009) 1.69
Gap junctions. Int Rev Cytol (1993) 1.67
Platelet endothelial cell adhesion molecule deficiency or blockade significantly reduces leukocyte emigration in a majority of mouse strains. J Immunol (2004) 1.64
Soluble domain 1 of platelet-endothelial cell adhesion molecule (PECAM) is sufficient to block transendothelial migration in vitro and in vivo. J Exp Med (1997) 1.60
Identification of a human endothelial cell antigen with monoclonal antibody 44G4 produced against a pre-B leukemic cell line. J Immunol (1988) 1.59
Human CD38 (ADP-ribosyl cyclase) is a counter-receptor of CD31, an Ig superfamily member. J Immunol (1998) 1.59
An anti-platelet-endothelial cell adhesion molecule-1 antibody inhibits leukocyte extravasation from mesenteric microvessels in vivo by blocking the passage through the basement membrane. J Exp Med (1996) 1.58
Biochemistry and expression of myelomonocytic antigens. J Immunol (1986) 1.56
Platelet/endothelial cell adhesion molecule-1 (CD31)-mediated cellular aggregation involves cell surface glycosaminoglycans. J Biol Chem (1993) 1.55
A heterophilic adhesion mechanism for platelet/endothelial cell adhesion molecule 1 (CD31). J Exp Med (1992) 1.55
Thrombospondin-1-deficient mice exhibit increased vascular density during retinal vascular development and are less sensitive to hyperoxia-mediated vessel obliteration. Dev Dyn (2003) 1.53
Mechanotransduction in endothelial cell migration. J Cell Biochem (2005) 1.53
CD105 antagonizes the inhibitory signaling of transforming growth factor beta1 on human vascular endothelial cells. FASEB J (2000) 1.50
Individually distinct Ig homology domains in PECAM-1 regulate homophilic binding and modulate receptor affinity. J Biol Chem (1996) 1.50
Extracellular and cytoplasmic domains of endoglin interact with the transforming growth factor-beta receptors I and II. J Biol Chem (2002) 1.49
In situ flow activates endothelial nitric oxide synthase in luminal caveolae of endothelium with rapid caveolin dissociation and calmodulin association. J Biol Chem (1998) 1.48
PECAM-1 mediates NO-dependent dilation of arterioles to high temporal gradients of shear stress. Arterioscler Thromb Vasc Biol (2005) 1.47
Streptavidin facilitates internalization and pulmonary targeting of an anti-endothelial cell antibody (platelet-endothelial cell adhesion molecule 1): a strategy for vascular immunotargeting of drugs. Proc Natl Acad Sci U S A (1999) 1.46
Immunotargeting of catalase to the pulmonary endothelium alleviates oxidative stress and reduces acute lung transplantation injury. Nat Biotechnol (2003) 1.46
Vascular endothelial cells synthesize a plasma membrane protein indistinguishable from the platelet membrane glycoprotein IIa. J Biol Chem (1985) 1.46
Dephosphorylation of endothelial nitric-oxide synthase by vascular endothelial growth factor. Implications for the vascular responses to cyclosporin A. J Biol Chem (2002) 1.44
Involvement of human PECAM-1 in angiogenesis and in vitro endothelial cell migration. Am J Physiol Cell Physiol (2002) 1.43
Chronic shear induces caveolae formation and alters ERK and Akt responses in endothelial cells. Am J Physiol Heart Circ Physiol (2003) 1.43
How do lymphocytes know where to go: current concepts and enigmas of lymphocyte homing. Adv Immunol (1997) 1.43
Identification of alpha v beta 3 as a heterotypic ligand for CD31/PECAM-1. J Cell Sci (1996) 1.42
The parting of the endothelium: miracle, or simply a junctional affair? J Cell Sci (2000) 1.42
PECAM-1 interacts with nitric oxide synthase in human endothelial cells: implication for flow-induced nitric oxide synthase activation. Arterioscler Thromb Vasc Biol (2004) 1.39
Platelet endothelial cell adhesion molecule-1 (PECAM-1) homophilic adhesion is mediated by immunoglobulin-like domains 1 and 2 and depends on the cytoplasmic domain and the level of surface expression. J Biol Chem (1996) 1.37
The emerging field of receptor-mediated inhibitory signaling: SHP or SHIP? Cell (1996) 1.35
Loss of PECAM-1 function impairs alveolarization. J Biol Chem (2005) 1.35
Activation-dependent changes in human platelet PECAM-1: phosphorylation, cytoskeletal association, and surface membrane redistribution. J Cell Biol (1992) 1.34